Ana Beatriz Gago-Veiga, Noelia Lopez-Alcaide, Sonia Quintas, Iris Fernández Lázaro, Javier Casas-Limón, Carlos Calle, Germán Latorre, Nuria González-García, Jesús Porta-Etessam, Jaime Rodriguez-Vico, Alex Jaimes, Andrea Gómez García, David García-Azorín, Ángel Luis Guerrero-Peral, Álvaro Sierra, Alberto Lozano Ros, Antonio Sánchez-Soblechero, Javier Díaz-de-Teran, Javier A Membrilla, Cristina Treviño, Alicia Gonzalez-Martinez
BACKGROUND AND PURPOSE: Anti-calcitonin gene-related peptide (CGRP) therapies are recent preventive therapies approved for both episodic and chronic migraine. One of the measures of effectiveness is the withdrawal of other preventive treatments. The objective of this study is to quantify the impact of anti-CGRP drugs in concomitant preventive treatment in patients with migraine. METHODS: This was an observational, retrospective, multicenter cohort study with patients from nine national headache units...
February 7, 2024: European Journal of Neurology